Lorna Jane, an Australian activewear company, was recently fined AU$5 million after claiming that its new line of active clothing can stop the spread of COVID-19. The firm said that its clothing could eliminate the virus, thus preventing its spread.
According to BBC News, Lorna Jane released advertisements that say it is using a groundbreaking technology called LJ Shield for its clothing line. It was claimed that this could stop the "transfer of all pathogens."
What the court says on Lorna Jane’s claims
Based on the report, a judge said in a ruling that the company’s claim about LJ Shield is "exploitative, predatory and potentially dangerous." The legal action against Lorna Jane was filed by the Australian Competition & Consumer Commission (ACCC) after the firm started selling its clothing in July amid the COVID-19 pandemic.
The verdict was said to have been released by the federal court on Friday, July 23. The judge said that based on investigations, Lorna Jane has been telling the consumers it has a “reasonable scientific or technological basis" for its claims about its clothing with the LJ Shield.
However, the judge said there was actually no scientific basis for such a claim. For this false and misleading representation to the public, the court slapped the company with a hefty fine.
"This was dreadful conduct as it involved making serious claims regarding public health when there was no basis for them," chairman of the ACCC, Rod Sims, said. "The whole marketing campaign was based upon consumers' desire for greater protection against the global pandemic."
Lorna Jane accepts the judge’s decision
The company was said to have accepted the verdict but explained, it was also misled by its supplier. Lorna Jane claimed its supplier sold them a product that did not deliver what it claimed to be, and they are referring to what they called the LJ Shield technology that is supposed to be anti-viral and anti-bacterial.
Meanwhile, it was learned that this is not the first time that Lorna Jane was fined. As per The Guardian, just in July 2020, the company was fined $40,000 for its failure to seek proper approval for ads from the Therapeutic Goods Administration. As for this new issue, the company issued an apology for its customers while continuing to blame its supplier for the issue.


Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results
Gold Prices Rise as Fed Rate Hike Bets Ease
Nvidia Secures $500 Billion AI Infrastructure Push With Wall Street Giants
S&P 500, Nasdaq Slip as Oil Jumps on Iran Tensions
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Singapore Raises 2026 GDP Growth Forecast to 4.5%-5.5% as AI Boom Fuels Economy
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Oil Prices Rise as US-Iran Talks Stall, Inflation Risks Grow
Airbus Joins Air India A320 Altitude Drop Probe
Asian Stocks Rise as Weak US Jobs Data Eases Fed Rate Hike Bets
Japan Posts First Current Account Deficit in 17 Months as Dividend Payments Surge
US Stock Futures Flat as Iran Strait of Hormuz Demands Fuel Oil Concerns
Japan Executives Warn Weak Yen and Currency Volatility Threaten Economy
Oil Prices Rise as Hormuz Reopening Remains Uncertain 



